Search for: "E.D. v. Pfizer, Inc."
Results 101 - 120
of 142
Sorted by Relevance
|
Sort by Date
15 Apr 2009, 4:44 am
Supp.2d ___, 2009 WL 307019, at *17-18 (E.D. [read post]
31 Dec 2014, 5:00 am
Ortho-McNeil-Janssen Pharmaceutical, Inc. v. [read post]
18 Mar 2011, 10:04 am
Pfizer, 196 F. [read post]
25 Apr 2016, 12:23 pm
Pfizer, Inc., 2016 WL 1222229 (D. [read post]
13 Sep 2007, 10:48 am
Jude Medical, Inc., 425 F.3d 1116, 1119-21 (8th Cir. 2005), and Castano v. [read post]
5 Apr 2013, 8:07 am
Pfizer, Inc., et al., No. 5:11-CV-69-DCB-JMR, 2013 U.S. [read post]
27 May 2010, 3:40 pm
”Merrell Dow Pharmaceuticals, Inc. v. [read post]
17 Sep 2009, 4:30 am
Medtronic, Inc., 128 S. [read post]
25 Jun 2009, 4:29 am
In re Amgen Inc. [read post]
11 Nov 2011, 11:55 am
”Day & Zimmerman, Inc. v. [read post]
7 May 2010, 5:00 am
The case of Ridgeway v Pfizer, Inc., No. 09-2794 (E.D. [read post]
30 Jun 2015, 2:57 am
In re GNC Corp., -- F.3d --, 2015 WL 3798174 (4thCir. [read post]
19 Apr 2013, 5:35 pm
Lowe’s Home Centers, Inc., 563 F. 3d 171, 178 (6th Cir 2009); Westberry v. [read post]
31 May 2007, 4:31 am
Pfizer, Inc., 2007 WL 1228784, at *3 (S.D. [read post]
9 Apr 2015, 5:00 am
Two other state supreme courts have reaffirmed the learned intermediary rule since then, Wyeth, Inc. v. [read post]
12 Jun 2014, 3:11 pm
Pfizer Pharms., Inc., 2011 WL 7659333, at *6-10 (S.D. [read post]
27 Jul 2012, 12:40 pm
Pfizer, Inc., 990 A.2d 17, 21 n.1 (Pa.Super. 2010) (rejecting fraud claim concerning promotion “for off-label uses for which the effectiveness had not been scientifically demonstrated”). [read post]
1 Apr 2015, 4:30 am
Pa. 2012); Steele v. [read post]
7 Oct 2010, 5:00 am
Pfizer Inc., 249 F.R.D. 248, 254 n.8 (E.D. [read post]
5 Jun 2013, 5:29 am
Oct. 24, 1996) Merrell Dow Pharms., Inc. v. [read post]
